Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven

Combination of chemotherapeutic agents and angiogenesis inhibitors is now commonly employed in the clinic to treat cancer. Here, we used angiostatic agents anginex and 0118, in combination with the chemotherapeutic irofulven, to treat human ovarian tumor xenografts in mice. General linear mixed mode...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Dings, Ruud P.M., Van Laar, Emily S., Webber, Jeremy, Zhang, Yan, Griffin, Robert J., Waters, Stephen J., MacDonald, John R., Mayo, Kevin H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3042303/
https://ncbi.nlm.nih.gov/pubmed/18378392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2008.02.048
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller